108 related articles for article (PubMed ID: 7805021)
41. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
[TBL] [Abstract][Full Text] [Related]
42. C-terminal peptides of p53 molecules enhance radiation-induced apoptosis in human mutant p53 cancer cells.
Ohnishi K; Inaba H; Yasumoto J; Yuki K; Takahashi A; Ohnishi T
Apoptosis; 2004 Sep; 9(5):591-7. PubMed ID: 15314287
[TBL] [Abstract][Full Text] [Related]
43. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
44. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
Fan S; Cherney B; Reinhold W; Rucker K; O'Connor PM
Clin Cancer Res; 1998 Apr; 4(4):1047-54. PubMed ID: 9563901
[TBL] [Abstract][Full Text] [Related]
45. The impact of p53 status on cellular sensitivity to antifolate drugs.
Lu X; Errington J; Curtin NJ; Lunec J; Newell DR
Clin Cancer Res; 2001 Jul; 7(7):2114-23. PubMed ID: 11448931
[TBL] [Abstract][Full Text] [Related]
46. The tumor suppressor p53 modifies mutational processes in a human lymphoblastoid cell line.
Xia F; Liber HL
Mutat Res; 1997 Jan; 373(1):87-97. PubMed ID: 9015157
[TBL] [Abstract][Full Text] [Related]
47. Radiation induced chromosome aberrations and clonogenic survival in human lymphoblastoid cell lines with different p53 status.
Geiger C; Weber KJ; Wenz F
Strahlenther Onkol; 1999 Jun; 175(6):289-92. PubMed ID: 10392171
[TBL] [Abstract][Full Text] [Related]
48. Apoptosis signals in lymphoblasts induced by focused ultrasound.
Abdollahi A; Domhan S; Jenne JW; Hallaj M; Dell'Aqua G; Mueckenthaler M; Richter A; Martin H; Debus J; Ansorge W; Hynynen K; Huber PE
FASEB J; 2004 Sep; 18(12):1413-4. PubMed ID: 15231731
[TBL] [Abstract][Full Text] [Related]
49. Mutagenicity of photodynamic therapy as compared to UVC and ionizing radiation in human and murine lymphoblast cell lines.
Evans HH; Horng MF; Ricanati M; Deahl JT; Oleinick NL
Photochem Photobiol; 1997 Nov; 66(5):690-6. PubMed ID: 9383992
[TBL] [Abstract][Full Text] [Related]
50. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53.
Li CQ; Robles AI; Hanigan CL; Hofseth LJ; Trudel LJ; Harris CC; Wogan GN
Cancer Res; 2004 May; 64(9):3022-9. PubMed ID: 15126337
[TBL] [Abstract][Full Text] [Related]
51. Fewer chromosome aberrations and earlier apoptosis induced by DNA synthesis inhibitors, a topoisomerase II inhibitor or alkylating agents in human cells with normal compared with mutant p53.
Greenwood SK; Armstrong MJ; Hill RB; Bradt CI; Johnson TE; Hilliard CA; Galloway SM
Mutat Res; 1998 Jun; 401(1-2):39-53. PubMed ID: 9639670
[TBL] [Abstract][Full Text] [Related]
52. Whole genome and normalized mRNA sequencing reveal genetic status of TK6, WTK1, and NH32 human B-lymphoblastoid cell lines.
Revollo J; Petibone DM; McKinzie P; Knox B; Morris SM; Ning B; Dobrovolsky VN
Mutat Res Genet Toxicol Environ Mutagen; 2016 Jan; 795():60-9. PubMed ID: 26774668
[TBL] [Abstract][Full Text] [Related]
53. Distinct signaling pathways after higher or lower doses of radiation in three closely related human lymphoblast cell lines.
Lu TP; Lai LC; Lin BI; Chen LH; Hsiao TH; Liber HL; Cook JA; Mitchell JB; Tsai MH; Chuang EY
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):212-9. PubMed ID: 20005454
[TBL] [Abstract][Full Text] [Related]
54. Ionizing radiation-induced mutation of human cells with different DNA repair capacities.
Amundson SA; Chen DJ
Adv Space Res; 1996; 18(1-2):119-26. PubMed ID: 11538952
[TBL] [Abstract][Full Text] [Related]
55. A comparison of the roles of p53 mutation and AraC inhibition in the enhancement of bleomycin-induced chromatid aberrations in mouse and human cells.
Allio T; Donner EM; Preston RJ
Mutat Res; 2000 Feb; 447(2):227-37. PubMed ID: 10751606
[TBL] [Abstract][Full Text] [Related]
56. Distinct apoptotic phenotypes induced by radiation and ceramide in both p53-wild-type and p53-mutated lymphoblastoid cells.
Shi YQ; Wuergler FE; Blattmann H; Crompton NE
Radiat Environ Biophys; 2001 Dec; 40(4):301-8. PubMed ID: 11820739
[TBL] [Abstract][Full Text] [Related]
57. Induction of telomerase activity by irradiation in human lymphoblasts.
Neuhof D; Ruess A; Wenz F; Weber KJ
Radiat Res; 2001 May; 155(5):693-7. PubMed ID: 11302766
[TBL] [Abstract][Full Text] [Related]
58. The effect of folate deficiency on the cytotoxic and mutagenic responses to ethyl methanesulfonate in human lymphoblastoid cell lines that differ in p53 status.
Branda RF; O'Neill JP; Brooks EM; Trombley LM; Nicklas JA
Mutat Res; 2001 Jan; 473(1):51-71. PubMed ID: 11166026
[TBL] [Abstract][Full Text] [Related]
59. Involvement of TP53 in apoptosis induced in human lymphoblastoid cells by fast neutrons.
Coelho D; Fischer B; Holl V; Jung GM; Dufour P; Bergerat JP; Denis JM; Gueulette J; Bischoff P
Radiat Res; 2002 Apr; 157(4):446-52. PubMed ID: 11893247
[TBL] [Abstract][Full Text] [Related]
60. Suppression of apoptosis and clonogenic survival in irradiated human lymphoblasts with different TP53 status.
Schäfer J; Bachtler J; Engling A; Little JB; Weber KJ; Wenz F
Radiat Res; 2002 Dec; 158(6):699-706. PubMed ID: 12452772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
